metastatic renal cell cancer
Showing 1 - 23 of 23
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Anti-OX40 Antibody PF-04518600
- +3 more
-
Los Angeles, California
- +9 more
Aug 5, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Cryosurgery
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 6, 2022
Metastatic Renal Cell Cancer Trial in United States (Axitinib)
Active, not recruiting
- Metastatic Renal Cell Cancer
-
Duarte, California
- +3 more
Jun 1, 2022
Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body
Recruiting
- Metastatic Renal Cell Cancer
- +2 more
- Stereotactic Body Radiation Therapy
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jun 3, 2022
Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)
Completed
- Metastatic Renal Cell Cancer
- Stage IV Renal Cell Cancer
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 8, 2022
Predict Treatment Efficacy in Renal Cell Carcinoma
Completed
- Metastatic Renal Cell Cancer
- perfusion computed tomography
-
Stanford, CaliforniaStanford University Cancer Institute
Jan 31, 2022
Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)
Active, not recruiting
- Kidney Neoplasms
- Metastatic Renal Cell Cancer
-
Besancon, Franche-Comté, FranceCHU Besancon
Nov 17, 2021
Myeloid Derived Suppressor Cells Clinical Assay in Finding
Recruiting
- Healthy Subject
- +5 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 16, 2021
Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic Trial in Meldola (FC) (Boost of radiotherapy + high dose IL-2
Recruiting
- Metastatic Renal Cell Cancer
- Malignant Melanoma, Metastatic
- Boost of radiotherapy + high dose IL-2 treatment
-
Meldola (FC), FC, ItalyUO Oncologia Medica, IRCCS IRST
Feb 25, 2021
Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia
Completed
- Adult Acute Myeloid Leukemia in Remission
- +29 more
- Fludarabine Phosphate
- +5 more
-
Tucson, Arizona
- +9 more
Dec 18, 2019
Metastatic Melanoma, Metastatic Renal Cell Cancer, Metastatic Cancer Trial run by the NCI (Anti-NY ESO-1 T-cell receptor PBL,
Terminated
- Metastatic Melanoma
- +2 more
- Anti-NY ESO-1 T-cell receptor PBL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 6, 2019
Metastatic Renal Cell Cancer Trial in Guangzhou (Cryosurgery, NK immunotherapy)
Completed
- Metastatic Renal Cell Cancer
- Cryosurgery
- NK immunotherapy
-
Guangzhou, Guangdong, ChinaCancer Institute in Fuda cancer hospital
Sep 10, 2019
Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (sunitinib)
Completed
- Metastatic Breast Cancer
- +11 more
-
Atlanta, Georgia
- +112 more
Jun 20, 2019
Metastatic Renal Cell Cancer Trial in Canada, United States (Drug: LY573636-sodium, Sunitinib)
Completed
- Metastatic Renal Cell Cancer
- Drug: LY573636-sodium
- Sunitinib
-
Indianapolis, Indiana
- +4 more
Dec 16, 2018
Advanced or Metastatic Hepatocellular Cancer, Advanced or Metastatic Ovarian Cancer, Metastatic Renal Cell Cancer Trial in
Completed
- Advanced or Metastatic Hepatocellular Cancer
- +3 more
-
Edegem, Belgium
- +23 more
Jan 4, 2019
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)
Completed
- Anaplastic Astrocytoma
- +64 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2016
Cognitive Function of Patients With Sunitinib or Sorafenib
Completed
- Metastatic Renal Cell Cancer
- GIST
-
Nijmegen, Gelderland, NetherlandsUniversity Medical Centre Nijmegen
Nov 1, 2011
Metastatic Renal Cell Cancer Trial in Worldwide (Everolimus)
No longer available
- Metastatic Renal Cell Cancer
-
Springdale, Arkansas
- +84 more
Aug 18, 2011